CytoSorbents Corp (CTSO)
0.8147
+0.01
(+1.58%)
USD |
NASDAQ |
Apr 22, 16:00
0.8147
0.00 (0.00%)
After-Hours: 20:00
CytoSorbents Enterprise Value: 35.14M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 22, 2024 | 35.14M |
April 19, 2024 | 34.46M |
April 18, 2024 | 34.40M |
April 17, 2024 | 33.80M |
April 16, 2024 | 34.22M |
April 15, 2024 | 37.97M |
April 12, 2024 | 38.26M |
April 11, 2024 | 40.04M |
April 10, 2024 | 43.03M |
April 09, 2024 | 44.11M |
April 08, 2024 | 43.16M |
April 05, 2024 | 45.75M |
April 04, 2024 | 42.76M |
April 03, 2024 | 41.11M |
April 02, 2024 | 42.76M |
April 01, 2024 | 40.26M |
March 28, 2024 | 42.49M |
March 27, 2024 | 41.40M |
March 26, 2024 | 39.23M |
March 25, 2024 | 40.17M |
March 22, 2024 | 39.23M |
March 21, 2024 | 37.60M |
March 20, 2024 | 38.08M |
March 19, 2024 | 39.23M |
March 18, 2024 | 43.36M |
Date | Value |
---|---|
March 15, 2024 | 38.69M |
March 14, 2024 | 43.57M |
March 13, 2024 | 45.75M |
March 12, 2024 | 45.21M |
March 11, 2024 | 47.38M |
March 08, 2024 | 47.38M |
March 07, 2024 | 46.83M |
March 06, 2024 | 44.12M |
March 05, 2024 | 43.20M |
March 04, 2024 | 42.49M |
March 01, 2024 | 42.37M |
February 29, 2024 | 42.93M |
February 28, 2024 | 43.52M |
February 27, 2024 | 42.98M |
February 26, 2024 | 44.27M |
February 23, 2024 | 44.07M |
February 22, 2024 | 44.61M |
February 21, 2024 | 45.15M |
February 20, 2024 | 46.24M |
February 16, 2024 | 45.69M |
February 15, 2024 | 45.69M |
February 14, 2024 | 45.69M |
February 13, 2024 | 45.69M |
February 12, 2024 | 45.15M |
February 09, 2024 | 46.24M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
22.13M
Minimum
Sep 26 2022
424.77M
Maximum
Feb 04 2021
172.80M
Average
145.59M
Median
Oct 18 2019
Enterprise Value Benchmarks
Delcath Systems Inc | 117.87M |
Star Equity Holdings Inc | 11.65M |
Exact Sciences Corp | 12.92B |
Illumina Inc | 19.55B |
Progyny Inc | 2.820B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -5.835M |
Revenue (Quarterly) | 7.348M |
Total Expenses (Quarterly) | 16.69M |
EPS Diluted (Quarterly) | -0.12 |
Gross Profit Margin (Quarterly) | 54.32% |
Profit Margin (Quarterly) | -79.40% |
Earnings Yield | -78.56% |
Normalized Earnings Yield | -82.77 |